Vanguard Group’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-840,754
| Closed | -$9.63M | – | 4370 |
|
|
2020
Q4 | $9.63M | Buy |
840,754
+17,931
| +2% | +$204K | ﹤0.01% | 3013 |
|
|
2020
Q3 | $5.68M | Buy |
822,823
+8,593
| +1% | +$56.4K | ﹤0.01% | 3089 |
|
|
2020
Q2 | $5.31M | Buy |
814,230
+89,557
| +12% | +$578K | ﹤0.01% | 3066 |
|
|
2020
Q1 | $4.79M | Buy |
724,673
+35,947
| +5% | +$313K | ﹤0.01% | 2991 |
|
|
2019
Q4 | $7.14M | Buy |
688,726
+12,378
| +2% | +$106K | ﹤0.01% | 3020 |
|
|
2019
Q3 | $4.28M | Sell |
676,348
-220,346
| -25% | -$1.64M | ﹤0.01% | 3193 |
|
|
2019
Q2 | $6.67M | Sell |
896,694
-516,912
| -37% | -$3.41M | ﹤0.01% | 3067 |
|
|
2019
Q1 | $8.68M | Buy |
1,413,606
+175,112
| +14% | +$2.03M | ﹤0.01% | 2902 |
|
|
2018
Q4 | $14.3M | Buy |
1,238,494
+80,893
| +7% | +$1.38M | ﹤0.01% | 2598 |
|
|
2018
Q3 | $25.1M | Buy |
1,157,601
+44,081
| +4% | +$834K | ﹤0.01% | 2480 |
|
|
2018
Q2 | $17.6M | Buy |
1,113,520
+55,291
| +5% | +$869K | ﹤0.01% | 2622 |
|
|
2018
Q1 | $19.9M | Sell |
1,058,229
-20,752
| -2% | -$409K | ﹤0.01% | 2498 |
|
|
2017
Q4 | $18.8M | Buy |
1,078,981
+49,028
| +5% | +$677K | ﹤0.01% | 2510 |
|
|
2017
Q3 | $15.4M | Buy |
1,029,953
+27,659
| +3% | +$435K | ﹤0.01% | 2598 |
|
|
2017
Q2 | $18.6M | Buy |
1,002,294
+73,526
| +8% | +$1.28M | ﹤0.01% | 2488 |
|
|
2017
Q1 | $15.7M | Buy |
928,768
+96,196
| +12% | +$1.92M | ﹤0.01% | 2550 |
|
|
2016
Q4 | $17.7M | Buy |
832,572
+164,099
| +25% | +$3.37M | ﹤0.01% | 2473 |
|
|
2016
Q3 | $12.2M | Buy |
668,473
+70,378
| +12% | +$1.59M | ﹤0.01% | 2591 |
|
|
2016
Q2 | $17.3M | Buy |
+598,095
| New | +$16.6M | ﹤0.01% | 2391 |
|
Vanguard Group's ARA Position: Q1 2021 in Review
Vanguard Group sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 840,754 shares — an estimated $9.63M sold.
Vanguard Group first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $25.1M in Q3 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Vanguard Group reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Vanguard Group sold 840,754 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $9.63M.
- Vanguard Group first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- Vanguard Group's American Renal Associates Holdings, Inc position peaked at $25.1M in Q3 2018.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Vanguard Group's 13F filing for Q1 2021, filed 14 May 2021.